(Q37829737)

24 August 2017

1 reference

title

Nanobody; an old concept and new vehicle for immunotargeting (English)

1 reference

24 August 2017

1

Fatemeh Rahbarizadeh

1 reference

24 August 2017

Davoud Ahmadvand

2

1 reference

24 August 2017

Zahra Sharifzadeh

series ordinal

3

1 reference

24 August 2017

publication date

11 January 2011

1 reference

Immunological Investigations

24 August 2017

published in

1 reference

24 August 2017

volume

40

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

299-338

1 reference

Immune response manipulation: recombinant immunoreceptors endow T-cells with predefined specificity

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Specific immuno capturing of the staphylococcal superantigen toxic-shock syndrome toxin-1 in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Cell selection and characterization of a novel human endothelial cell specific nanobody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Production and characterization of a high-affinity nanobody against human endoglin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Regression of experimental medulloblastoma following transfer of HER2-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

A llama single domain anti-idiotypic antibody mimicking HER2 as a vaccine: Immunogenicity and efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

TNT detection using llama antibodies and a two-step competitive fluid array immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Multiplexed fluid array screening of phage displayed anti-ricin single domain antibodies for rapid assessment of specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Selection and identification of single domain antibody fragments from camel heavy-chain antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Prokaryotic expression of antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Treatment of malignancy with unmodified antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Anti-MUC1 nanobody can redirect T-body cytotoxic effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Isolation and characterization of anti-FcgammaRIII (CD16) llama single-domain antibodies that activate natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Contributions of CDR3 to V H H domain stability and the design of monobody scaffolds for naive antibody libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Kinetic analysis of recombinant antibody-antigen interactions: relation between structural domains and antigen binding

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Improving the efficacy of antibody-based cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

PEGylated antibodies and antibody fragments for improved therapy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Domain association in immunoglobulin molecules. The packing of variable domains

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Efficient cancer therapy with a nanobody-based conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Efficient tumor targeting by single-domain antibody fragments of camels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Antibody VH domains as small recognition units

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Nanobodies as tools for in vivo imaging of specific immune cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Llama antibodies against a lactococcal protein located at the tip of the phage tail prevent phage infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Canonical antigen-binding loop structures in immunoglobulins: more structures, more canonical classes?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Nanobodies, a promising tool for species-specific diagnosis of Taenia solium cysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Intracellularly Expressed Single-Domain Antibody against p15 Matrix Protein Prevents the Production of Porcine Retroviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

An alpaca single-domain antibody blocks filopodia formation by obstructing L-plastin-mediated F-actin bundling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Three camelid VHH domains in complex with porcine pancreatic alpha-amylase. Inhibition and versatility of binding topology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Structural analysis, selection, and ontogeny of the shark new antigen receptor (IgNAR): identification of a new locus preferentially expressed in early development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Use of tumour-responsive T cells as cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Isolation of llama antibody fragments for prevention of dandruff by phage display in shampoo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Single domain antibodies are specially suited for quantitative determination of gliadins under denaturing conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

A Single-Domain Llama Antibody Potently Inhibits the Enzymatic Activity of Botulinum Neurotoxin by Binding to the Non-Catalytic α-Exosite Binding Region

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Selection and characterization of naturally occurring single-domain (IgNAR) antibody fragments from immunized sharks by phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Cloning, expression, and characterization of a single-domain antibody fragment with affinity for 15-acetyl-deoxynivalenol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

CD105 is important for angiogenesis: evidence and potential applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Single-domain antibody fragments with high conformational stability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Llama single-chain antibody that blocks lipopolysaccharide binding and signaling: prospects for therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Antidotes against venomous animals: state of the art and prospectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Biophysical properties of human antibody variable domains

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

A comparison of strategies to stabilize immunoglobulin Fv-fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Facile generation of heat-stable antiviral and antitoxin single domain antibodies from a semisynthetic llama library

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Thermostable llama single domain antibodies for detection of botulinum A neurotoxin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Isolation of novel EGFR-specific VHH domains

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Reverse proteomic antibody screening identifies anti adhesive VHH targeting VLA-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Identification by phage display of single-domain antibody fragments specific for the ODD domain in hypoxia-inducible factor 1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Identification of single-domain, Bax-specific intrabodies that confer resistance to mammalian cells against oxidative-stress-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Naturally occurring antibodies devoid of light chains

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Properties, production, and applications of camelid single-domain antibody fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Prolonged in vivo residence times of llama single-domain antibody fragments in pigs by binding to porcine immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Enhancement of toxin- and virus-neutralizing capacity of single-domain antibody fragments by N-glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Escherichia coli F4 fimbriae specific llama single-domain antibody fragments effectively inhibit bacterial adhesion in vitro but poorly protect against diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Passive immunization of guinea pigs with llama single-domain antibody fragments against foot-and-mouth disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Selection and optimization of proteolytically stable llama single-domain antibody fragments for oral immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Neutralisation of venom-induced haemorrhage by IgG from camels and llamas immunised with viper venom and also by endogenous, non-IgG components in camelid sera

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Structure-immunogenicity relationships of therapeutic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI'.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Lactobacillli expressing llama VHH fragments neutralise Lactococcus phages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Immunogenicity of engineered antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Loss-of-function screening by randomized intracellular antibodies: identification of hnRNP-K as a potential target for metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Production and characterization of anti-(mucin MUC1) single-domain antibody in tobacco (Nicotiana tabacum cultivar Xanthi).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Replacing the complementarity-determining regions in a human antibody with those from a mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

A single-step procedure of recombinant library construction for the selection of efficiently produced llama VH binders directed against cancer markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Modulation of protein properties in living cells using nanobodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Improved anti-IgG and HSA affinity ligands: clinical application of VHH antibody technology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Continuous cultures of fused cells secreting antibody of predefined specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Single domain antibodies from llama effectively and specifically block T cell ecto-ADP-ribosyltransferase ART2.2 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Enzyme mimicry by the antiidiotypic antibody approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Crystal Structure of the N-Terminal Domain of the Secretin GspD from ETEC Determined with the Assistance of a Nanobody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Isolation and characterization of a thermally stable recombinant anti-caffeine heavy-chain antibody fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Single-domain antibodies recognize selectively small oligomeric forms of amyloid beta, prevent Abeta-induced neurotoxicity and inhibit fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Recognition of the intrinsically flexible addiction antidote MazE by a dromedary single domain antibody fragment. Structure, thermodynamics of binding, stability, and influence on interactions with DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Nanobody-aided structure determination of the EpsI:EpsJ pseudopilin heterodimer from Vibrio vulnificus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Studies on the antibody response of Lama glama--evaluation of the binding capacity of different IgG subtypes in ELISAs for clenbuterol and BSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Potent enzyme inhibitors derived from dromedary heavy-chain antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Construction and evaluation of novel fusion proteins for targeted delivery of micro particles to cellulose surfaces.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Pentabody-mediated antigen delivery induces antigen-specific mucosal immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Characterization of a monoclonal anti-idiotype antibody to human anti-factor VIII antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

ES1, a new lung carcinoma antibody--an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Affinity selection of a camelized V(H) domain antibody inhibitor of hepatitis C virus NS3 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Free prostate-specific antigen in serum is becoming more complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Camelid immunoglobulins and nanobody technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Camel heavy-chain antibodies: diverse germline V(H)H and specific mechanisms enlarge the antigen-binding repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Selection and affinity maturation of IgNAR variable domains targeting Plasmodium falciparum AMA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Isolation of the new antigen receptor from wobbegong sharks, and use as a scaffold for the display of protein loop libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Heating as a rapid purification method for recovering correctly-folded thermotolerant VH and VHH domains

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Downregulation of EGFR by a novel multivalent nanobody-liposome platform.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Production of a novel camel single-domain antibody specific for the type III mutant EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Bacteria as tumour-targeting vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Llama VHH antibody fragments against GFAP: better diffusion in fixed tissues than classical monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

An S-layer heavy chain camel antibody fusion protein for generation of a nanopatterned sensing layer to detect the prostate-specific antigen by surface plasmon resonance technology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Engineering of therapeutic antibodies to minimize immunogenicity and optimize function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

High expression and purification of the recombinant camelid anti-MUC1 single domain antibodies in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Over expression of anti-MUC1 single-domain antibody fragments in the yeast Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Production of novel recombinant single-domain antibodies against tandem repeat region of MUC1 mucin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Production of chimeric recombinant single domain antibody-green fluorescent fusion protein in Chinese hamster ovary cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Relevance of the diversity among members of the Trypanosoma cruzi trans-sialidase family analyzed with camelids single-domain antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Monoclonal antibodies as innovative therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Reshaping human antibodies for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Nanobodies as novel agents for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Angiogenesis and anti-angiogenesis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Targeting and tracing antigens in live cells with fluorescent nanobodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Isolation of antigen-binding camelid heavy chain antibody fragments (nanobodies) from an immune library displayed on the surface of Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

The promise and potential pitfalls of chimeric antigen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Targeting tumours with genetically enhanced T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Engineering camel single-domain antibodies and immobilization chemistry for human prostate-specific antigen sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Single-domain antibodies as building blocks for novel therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Single domain antibodies derived from dromedary lymph node and peripheral blood lymphocytes sensing conformational variants of prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Llama-derived single-domain intrabodies inhibit secretion of hepatitis B virions in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Challenges in therapeutic glycoprotein production

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Selection, characterization, and CDR shuffling of naive llama single-domain antibodies selected against auxin and their cross-reactivity with auxinic herbicides from four chemical families

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Rapid assembly of sensitive antigen-capture assays for Marburg virus, using in vitro selection of llama single-domain antibodies, at biosafety level 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

A novel designed single domain antibody on 3-D structure of ricin A chain remarkably blocked ricin-induced cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Dimerisation strategies for shark IgNAR single domain antibody fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Assembly of a functional immunoglobulin Fv fragment in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Prolonged in vivo residence times of antibody fragments associated with albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Lateral recognition of a dye hapten by a llama VHH domain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

The crystal structure of a llama heavy chain variable domain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Camelid heavy-chain variable domains provide efficient combining sites to haptens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Crystal structure of a shark single-domain antibody V region in complex with lysozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Isolation, characterization and pentamerization of alpha-cobrotoxin specific single-domain antibodies from a naïve phage display library: preliminary findings for antivenom development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Structural evidence for evolution of shark Ig new antigen receptor variable domain antibodies from a cell-surface receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Design of a peptibody consisting of the antimicrobial peptide dhvar5 and a llama variable heavy-chain antibody fragment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Selection by phage display of llama conventional V(H) fragments with heavy chain antibody V(H)H properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

PrP-specific camel antibodies with the ability to immunodetect intracellular prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

MUC1 and the immunobiology of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

High-level expression of Camelid nanobodies in Nicotiana benthamiana

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Specific production rate of VHH antibody fragments by Saccharomyces cerevisiae is correlated with growth rate, independent of nutrient limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Camel single-domain antibody inhibits enzyme by mimicking carbohydrate substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Increased heterologous protein production by Saccharomyces cerevisiae growing on ethanol as sole carbon source.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

A llama-derived gelsolin single-domain antibody blocks gelsolin-G-actin interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Improved production and function of llama heavy chain antibody fragments by molecular evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Llama-derived phage display antibodies in the dissection of the human disease oculopharyngeal muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Structural tolerance of bacterial autotransporters for folded passenger protein domains

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

An intrabody based on a llama single-domain antibody targeting the N-terminal alpha-helical multimerization domain of HIV-1 rev prevents viral production.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Solution structure of a llama single-domain antibody with hydrophobic residues typical of the VH/VL interface

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Applications of single-chain variable fragment antibodies in therapeutics and diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Length distribution of CDRH3 in antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Selection of hapten-specific single-domain antibodies from a non-immunized llama ribosome display library

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Llama single domain antibodies as a tool for molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Pentamerization of single-domain antibodies from phage libraries: a novel strategy for the rapid generation of high-avidity antibody reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Humanization of an anti-human TNF-alpha antibody by variable region resurfacing with the aid of molecular modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Trials and tribulations: oncological antibody imaging comes to the fore

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

1H, 13C and 15N assignments of a camelid nanobody directed against human α-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

The Production and Characterization of Novel Heavy-Chain Antibodies Against the Tandem Repeat Region of MUC1 Mucin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Isolation of a Novel Nanobody Against HER-2/neuUsing Phage Displays Technology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Antigen Binding and Solubility Effects upon the Veneering of a Camel VHH in Framework-2 to Mimic a VH

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Biophysical Properties of Camelid VHHDomains Compared to Those of Human VH3 Domains†

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

A bispecific nanobody to provide full protection against lethal scorpion envenoming

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Comparison of llama VH sequences from conventional and heavy chain antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

The Development of Primary and Secondary Lymphoid Tissues in the Nurse SharkGinglymostoma cirratum: B-Cell Zones Precede Dendritic Cell Immigration and T-Cell Zone Formation During Ontogeny of the Spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

Production of functional chimaeric mouse/human antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.542228

10.3109/08820139.2010.542228

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference